Dad's death spurs Singaporean in cancer vaccine research in US

FDA has approved vaccine she worked on, with first phase of clinical trials to be held next year

Dr Noor Faezzah Baharom, a postdoctoral fellow at the US National Institutes of Health, said her father's cancer diagnosis strengthened her conviction to translate her research into something that can help people. Her father died in March this year.
Dr Noor Faezzah Baharom, a postdoctoral fellow at the US National Institutes of Health, said her father's cancer diagnosis strengthened her conviction to translate her research into something that can help people. Her father died in March this year. PHOTO: COURTESY OF NOOR FAEZZAH BAHAROM
New: Gift this subscriber-only story to your friends and family

A year and a half after she moved to the United States to start work on a cancer vaccine, Dr Noor Faezzah Baharom received news that her father had been diagnosed with stomach cancer.

His battle with the ailment and death in March this year, just more than a year after his diagnosis in December 2018, strengthened her resolve to research and develop a cancer vaccine in the hopes of helping other patients.

Already a subscriber? 

Dive deeper at $0.99/month

Want more exclusives, sharp insights into what's happening at home and abroad? Subscribe to stay informed.

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • 2-week e-paper archive so you never miss out on any topic that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.

A version of this article appeared in the print edition of The Sunday Times on November 22, 2020, with the headline Dad's death spurs Singaporean in cancer vaccine research in US. Subscribe